AxoGen, Inc. Announces 2015 Annual Shareholders’ Meeting
Thursday, May 28, 2015 at 1:00pm Eastern Time
ALACHUA, FL, April 27, 2015 – AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company dedicated to peripheral nerve repair, announced today that it will hold its Annual Shareholders’ Meeting on Thursday, May 28, 2015. The Meeting will take place at 1:00 pm ET at the following location:
Hyatt Regency Orlando International Airport – Orly Room
9300 Jeff Fuqua Blvd.
Orlando, FL 32827
Shareholders may also attend the Meeting via phone or internet link as follows:
Phone: 1.877.317.6789 or 1.412.317.6789
Internet Link: https://www.virtualshareholdermeeting.com/axogen15
The Proxy Statement, with the accompanying Notice of Annual Meeting, and 2014 Annual Report on Form 10–K are available on the Company’s website at http://ir.axogeninc.com/proxy-statements#.
Shareholders of record of the Company’s common stock at the close of business on April 1, 2015 will be entitled to receive notice of and to vote at the Meeting.
About AxoGen, Inc.
AxoGen (NASDAQ: AXGN) is a leading medical technology company dedicated to peripheral nerve repair. AxoGen’s portfolio of regenerative medicine products is available in the United States, Canada and several other countries and includes Avance® Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site, AxoGuard® Nerve Connector, a porcine submucosa extracellular matrix (“ECM”) coaptation aid for tensionless repair of severed nerves, and AxoGuard® Nerve Protector, a porcine submucosa ECM product used to wrap and protect injured peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments.
Avance® Nerve Graft is processed in the United States by AxoGen. AxoGuard® Nerve Connector and AxoGuard® Nerve Protector are manufactured in the United States by Cook Biotech Incorporated, and are distributed worldwide exclusively by AxoGen. AxoGen maintains its corporate offices in Alachua, Florida and is the parent of its wholly owned operating subsidiary, AxoGen Corporation.
For more information about AxoGen or to sign up for our news alerts, please visit www.AxoGenInc.com.
Help employers find you! Check out all the jobs and post your resume.
ALACHUA, FL, April 27, 2015 – AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company dedicated to peripheral nerve repair, announced today that it will hold its Annual Shareholders’ Meeting on Thursday, May 28, 2015. The Meeting will take place at 1:00 pm ET at the following location:
Hyatt Regency Orlando International Airport – Orly Room
9300 Jeff Fuqua Blvd.
Orlando, FL 32827
Shareholders may also attend the Meeting via phone or internet link as follows:
Phone: 1.877.317.6789 or 1.412.317.6789
Internet Link: https://www.virtualshareholdermeeting.com/axogen15
The Proxy Statement, with the accompanying Notice of Annual Meeting, and 2014 Annual Report on Form 10–K are available on the Company’s website at http://ir.axogeninc.com/proxy-statements#.
Shareholders of record of the Company’s common stock at the close of business on April 1, 2015 will be entitled to receive notice of and to vote at the Meeting.
About AxoGen, Inc.
AxoGen (NASDAQ: AXGN) is a leading medical technology company dedicated to peripheral nerve repair. AxoGen’s portfolio of regenerative medicine products is available in the United States, Canada and several other countries and includes Avance® Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site, AxoGuard® Nerve Connector, a porcine submucosa extracellular matrix (“ECM”) coaptation aid for tensionless repair of severed nerves, and AxoGuard® Nerve Protector, a porcine submucosa ECM product used to wrap and protect injured peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments.
Avance® Nerve Graft is processed in the United States by AxoGen. AxoGuard® Nerve Connector and AxoGuard® Nerve Protector are manufactured in the United States by Cook Biotech Incorporated, and are distributed worldwide exclusively by AxoGen. AxoGen maintains its corporate offices in Alachua, Florida and is the parent of its wholly owned operating subsidiary, AxoGen Corporation.
For more information about AxoGen or to sign up for our news alerts, please visit www.AxoGenInc.com.
Help employers find you! Check out all the jobs and post your resume.